← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE AND LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-03-28

Drug application

FDA Application #

ANDA091144

Application type

Abbreviated New Drug Application (Generic)

Brand name

ABACAVIR SULFATE AND LAMIVUDINE

Generic name

ABACAVIR AND LAMIVUDINE

Active ingredients

ABACAVIR SULFATE; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2017-03-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown